HAMBURG and BENSHEIM, Germany, January 12, 2022 / CNW / – Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”), a distributor of CBD medical cannabis and wellness products in Germany, announces that its wholly owned subsidiary, AMP Alternative Medical Products GmbH (“AMP”) and Eurox Pharma GmbH (“Eurox”), one of the Europe leading medical cannabis companies, the start of sales of Dronabinol produced in Germany by Eurox.
Dronabinol is pure tetrahydrocannabinol (THC) and is registered as an active pharmaceutical ingredient (API) and has been registered for sale with the relevant authorities in Germany. Doctors and pharmacists can find more information about the product or order on the AMP website: https://amp-eu.com/doccheck-login/
AMP and Eurox have entered into a non-exclusive agreement for the marketing and distribution of Dronabinol intended for sale in pharmacies from February 2022. With a view to starting marketing in pharmacies, AMP trained its national sales team on the benefits of Dronabinol for patients to doctors and preparation methods for pharmacists.
Eurox was one of the first medical cannabis companies to produce Dronabinol manufactured in Germany to one of Europe the largest GMP installations located in Hesse, Germany and controls the entire supply chain from cultivation, production to distribution ensuring a stable and efficient supply to its customers.
Neil smith, the president of Eurox declared: “If you believe in ‘Made in Germany‘, then it means Eurox. AMP’s focus on German patient service and national sales coverage make it an ideal partner for us. “
Dr. Stefan Feuerstein, President and CEO of Greenrise Global and CEO of AMP, “The German market turns to pharmaceuticals as health authorities strengthen their regulatory oversight to ensure patient safety. Dronabinol is a well established product in Germany, and we expect it to be one of our best-selling products this year. “
About Eurox Pharma
Eurox Pharma is one of Europe leading medical cannabis companies. Eurox is vertically integrated, with:
100% German subsidiaries responsible for product development and intellectual property.
EU GMP manufacturing in Germany with a German pharmaceutical partner.
A cultivation facility at Portugal to ensure vertical integration and independence of supply.
A significant minority stake in Integro Medical Clinics, a UK registered medical cannabis clinic.
Various high-caliber distribution partnerships in Germany and other European countries and its own sales team.
For more information on Eurox, please visit www.eurox-pharma.com
About Greenrise Global Brands
Greenrise Global helps people realize the beneficial properties of cannabis. Greenrise Global is a publicly traded Canadian company with two German operating subsidiaries: Greenrise GmbH (“Greenrise Wellbeing”) and AMP Alternative Medical Products GmbH (“AMP”). Greenrise Wellbeing is a CBD wellness company based in Hamburg, with brands including Herbify and CANAVEX® in his wallet.
AMP is based in Erfurt and supplies medical cannabis products to pharmacies across Germany, including the medical cannabis brands of Aphria, Bedrocan, Little Green Pharma and CHArange of branded products and sold through its national sales team. The AMP complies with the German Narcotics Act (BtMG) and the regulatory requirements of the Free State of Thuringia, ensuring that products imported from all over the world and sold in Germany meet the European Union Good Manufacturing Practices (EU-GMP) standard.
For more information on Greenrise Global, please visit https://greenriseglobal.com/
FOLLOW US ON:
Neither CSE nor its regulatory services provider (as that term is defined in CSE policies) accepts responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and timelines. Although the Company believes that the expectations expressed in these forward-looking statements are based on reasonable assumptions, these statements do not guarantee future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company does not undertake to update them publicly to reflect new information or the occurrence of future events or circumstances, unless the law does not require otherwise.
SOURCE Greenrise Global Brands Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2022/12/c8933.html